Atsushi Kumanogoh

This inventor holds 8 USPTO granted patents and 9 published patent applications, plus 2 CIPO patents and 3 EPO patents. Top assignees: Osaka University, Chugai Seiyaku Kabushiki Kaisha, Boehringer Ingelheim International Gmbh. Active years: 2008-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Atsushi Kumanogoh. Retrieved from https://idiyas.com/inventor/atsushi-kumanogoh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 (Patent Applications = 9)

% Patents Active = 100.0

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 3 (Patent Applications = 9)

Average Co-Inventor Count = 2.3

ph-index = 2

Forward Citations = 10(Granted Patents)

Location History:

Suita, JP (2020 - 2021)
Osaka, JP (2008 - 2023)

Company Filing History:

Chugai Seiyaku Kabushiki Kaisha

patents

1 out of 1,562

Boehringer Ingelheim International Gmbh

patents

where one patent can have more than one assignee

Years Active: 2008-2026

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12735478 - ANTI-CD98hc ANTIBODY (2026-09-15),

2. 12474337 - THERAPEUTIC AGENT FOR AUTOIMMUNE DISEASES OR ALLERGY, AND METHOD FOR SCREENING FOR THE THERAPEUTIC AGENT (2025-11-18),

3. 11576969 - AntiPlexin A1 agonist antibody (2023-02-14),

4. 10988540 - Antibody (2021-04-27),

5. 10794907 - Therapeutic agent for autoimmune diseases or allergy, and method for screening for the therapeutic agent (2020-10-06),

6. 10688178 - AntiPlexin A1 agonist antibody (2020-06-23),

7. 10654931 - Antibody (2020-05-19),

8. 7462461 - Compositions for inhibiting Sema7A and VLA-1 interaction and the methods of using the same (2008-12-09),

Title: Atsushi Kumanogoh: Innovator in Antibody Research

Introduction

Atsushi Kumanogoh is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of antibody research, holding a total of 8 patents. His work focuses on developing novel therapeutic antibodies that have the potential to treat various medical conditions.

Latest Patents

One of his latest patents is the Anti-Plexin A1 agonist antibody. This innovative antibody promotes dendritic cell contraction, which could have implications for immune response modulation. Additionally, he has developed an antibody that serves as an active ingredient in a pharmaceutical composition for treating myeloma. This specific antibody targets an epitope present in the region of amino acid residue positions 20 to 109 of human integrin β.

Career Highlights

Atsushi Kumanogoh has worked with esteemed institutions such as Osaka University and Chugai Seiyaku Co., Ltd. His research has been pivotal in advancing the understanding of antibody mechanisms and their applications in medicine.

Collaborations

He has collaborated with notable colleagues, including Naoki Hosen and Haruo Sugiyama, to further his research endeavors.

Conclusion

Atsushi Kumanogoh's contributions to antibody research exemplify his dedication to innovation in the medical field. His patents and collaborations highlight the importance of teamwork in advancing scientific knowledge.

Profile summary based on public USPTO records.